Funke M, Kim M, Hasse C, Bartsch D, Rothmund M
Klinik für Allgemeinchirurgie, Philipps-Universität Marburg.
Dtsch Med Wochenschr. 1997 Nov 28;122(48):1475-81. doi: 10.1055/s-2008-1047788.
Primary hyperparathyroidism (PHPT) is being diagnosed ever more frequently. After diabetes mellitus, ovarian dysfunction and metabolic disorders it is now among the most frequent metabolic disease. Its surgical treatment has become standardized with increasing experience. A prospective study was undertaken to clarify to what extent our own standardized diagnostic and therapeutic measures conform to current standards in literature.
During 10 years (1. 1. 1987-31. 12. 1996) 478 patients with PHPT were treated surgically (solitary adenoma: 317 (76.5%), multiple lobe hyperplasias 66 (15.9%), double adenoma 28 (6.8%), and carcinoma 4 (0.8%). PHPT was part of the MEN (multiple endocrine neoplasia) syndrome in 20 patients. Typical symptoms of PHPT had been present in 400 patients (83.7%), while 78 (16.3%) had no manifest symptoms. Ultrasound examination of the soft tissues was the only preoperative test of localization. More extensive preoperative diagnosis was practised only before reoperations. All patients had bilateral exploration of the neck to try and demonstrate all four epithelial bodies.
A primary operation normalized the calcium level in 405 of 414 patients (97.8%). In 64 previously unsuccessfully operated patients who were reoperated for persisting HPT the elevated calcium levels could be normalized in 90.6%. Hypercalcaemia was finally abolished in all 478 patients. Average follow-up duration for 319 patients was more than 4.8 (0.5-8.5) years. The perioperative mortality rate was 0.8 (4 of 478), with 41 deaths during the later follow-up period. Permanent recurrent laryngeal nerve palsy occurred in 6 patients (1.8%). Long-term calcium substitution was necessary postoperatively in four patients (1.2%).
Our findings support a liberal policy towards indication for bilateral surgical exploration of the neck in PHPT.
原发性甲状旁腺功能亢进症(PHPT)的诊断越来越频繁。继糖尿病、卵巢功能障碍和代谢紊乱之后,它现在是最常见的代谢性疾病之一。随着经验的增加,其外科治疗已变得标准化。进行了一项前瞻性研究,以明确我们自己的标准化诊断和治疗措施在多大程度上符合文献中的当前标准。
在10年期间(1987年1月1日至1996年12月31日),对478例PHPT患者进行了手术治疗(孤立性腺瘤:317例(76.5%),多叶增生66例(15.9%),双腺瘤28例(6.8%),癌4例(0.8%))。20例患者的PHPT是多内分泌腺瘤(MEN)综合征的一部分。400例患者(83.7%)有PHPT的典型症状,而78例(16.3%)没有明显症状。软组织超声检查是唯一的术前定位检查。仅在再次手术前进行更广泛的术前诊断。所有患者均进行双侧颈部探查,试图显示所有四个甲状旁腺。
414例患者中的405例(97.8%)初次手术后血钙水平恢复正常。64例先前手术未成功且因持续性甲状旁腺功能亢进症再次手术的患者中,90.6%的患者血钙升高水平得以恢复正常。478例患者最终均消除了高钙血症。319例患者的平均随访时间超过4.8(0.5 - 8.5)年。围手术期死亡率为0.8%(478例中有4例),后期随访期间有41例死亡。6例患者(1.8%)发生永久性喉返神经麻痹。4例患者(1.2%)术后需要长期补钙。
我们的研究结果支持对PHPT患者双侧颈部手术探查指征采取宽松的政策。